In patients with symptoms such as irregular heartbeats, dizziness, or fainting, or in individuals that physicians suspect may ...
Application segment, which is expected to reach US$1.3 Billion by 2030 with a CAGR of a 8%. The AISS (Clinical) Application ...
Australian medical technology company Optalert has revealed a breakthrough test for sleep issues, expanding access to sleep health technologies for millions of Australians.